Experiences in the nationwide program for the integral care of the patient with diabetic foot ulcer using Heberprot-P. The Cuban product Heberprot-P is indicated for the treatment of complex diabetic foot ulcers (DFU). After its registration in 2006. the product was included into the Cuban List of Medicines and a nationwide program for the integral care of the DFU patient began. https://www.bempresas.com/